Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
576 studies found for:    Motor Neuron Diseases
Show Display Options
Rank Status Study
21 Completed Study of "Post-Polio Syndrome"
Conditions: Poliomyelitis;   Postpoliomyelitis Syndrome
Intervention:
22 Not yet recruiting Deep Phenotyping in Patients With ALS
Conditions: ALS;   Motor Neuron Disease
Intervention:
23 Completed Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders
Conditions: Deglutition Disorder;   Motor Neuron Disease
Intervention:
24 Recruiting MRI Biomarkers in ALS
Conditions: Amyotrophic Lateral Sclerosis;   ALS;   Motor Neuron Diseases
Intervention: Other: Magnetic Resonance Imaging
25 Unknown  Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis
Conditions: Amyotrophic Lateral Sclerosis;   Motor Neuron Disease
Intervention: Device: noninvasive positive pressure ventilation
26 Completed Efficacy of Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)
Conditions: Amyotrophic Lateral Sclerosis;   Motor Neuron Disease
Intervention:
27 Recruiting Genomic Translation for ALS Care
Condition: ALS
Intervention:
28 Terminated Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Thalidomide (drug)
29 Completed Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
Conditions: Amyotrophic Lateral Sclerosis;   Lou Gehrig's Disease;   Primary Lateral Sclerosis;   Nervous System Diseases;   Hereditary Spastic Paraparesis
Intervention: Other: No intervention
30 Recruiting EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
Conditions: Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:
31 Not yet recruiting Evaluation of Usability and Human Factors in the Novus System
Conditions: Drop Foot;   Muscle Weakness;   Motor Neuron Disease, Upper
Intervention: Device: Novus system
32 Recruiting Amyotrophic Lateral Sclerosis and the Innate Immune System
Conditions: Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:
33 Completed Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population
Conditions: Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:
34 Terminated Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology
Conditions: Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:
35 Terminated Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient
Conditions: Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:
36 Terminated Phase 3 Extension Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Dexpramipexole
37 Completed GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: GM604;   Drug: Placebo comparator
38 Recruiting Muscle Oxygenation in Effort in Neuromuscular Diseases
Condition: Neuromuscular Diseases
Intervention: Other: muscle oxygenation
39 Terminated Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
Conditions: Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:
40 Completed Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis
Conditions: Amyotrophic Lateral Sclerosis;   Motor Neuron Disease;   Lou Gehrig's Disease
Intervention: Behavioral: Treadmill Exercise

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.